Evaluation of potential immunogenicity differences between Pandemrix™ and Arepanrix™

In retrospective observational studies, an increased relative risk of incident narcolepsy was observed in some European countries among recipients of the AS03-adjuvanted, A(H1N1)pdm09, inactivated, detergent-split virion vaccine Pandemrix™ manufactured in Dresden, Germany (D-Pan H1N1). A similar inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Canelle, Quentin, Dewé, Walthère, Innis, Bruce L., van der Most, Robbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027709/
https://www.ncbi.nlm.nih.gov/pubmed/27105343
http://dx.doi.org/10.1080/21645515.2016.1168954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027709/
https://www.ncbi.nlm.nih.gov/pubmed/27105343
http://dx.doi.org/10.1080/21645515.2016.1168954

Ejemplares similares